Russell Sass

Partner at Dla Piper @DLA Piper

Experience: I advise clients with respect to corporate, commercial, and regulatory matters relating to the healthcare industry. I service a variety of clients, including private equity firms and strategic investors, healthcare facilities and providers in mergers and acquisitions, joint ventures, governance matters, general business transactions and healthcare regulatory matters, including Stark, Anti-Kickback and corporate practice of medicine analysis.Representative Matters:Represented New Jersey Urology, the leading urology service provider in New Jersey, in its partnership and restructuring with J.W. Childs Associates, a leading middle-market private equity firm, in forming Urology Management Associates that provides administrative services to NJU. Represented North American Dental Group in its acquisition of multiple dental clinics. Represented Abry Partners in its acquisition of Dr. Dental. Represented ROARK in its acquisition of Great Expression Dental Centers. Represented Warburg Pincus in the acquisition of CityMD, a New York and New Jersey based urgent care providerCurrently representing private equity fund in acquisition of New York based population health management platformCurrently representing private equity fund in acquisition of New York based walk-in clinics/medical practiceRepresented Gastro Health in its partnership and restructuring with The Audax GroupCurrently representing large dermatology platform in partnership with private equity fundRepresented Skin and Cancer Associates LLP in the sale of its partnership interests to SPC Dermatology Partners, LLCRepresented Advanced Surgery Center in connection with its partnership with Surgery Partners, Inc.Currently representing New York based dental health insurance platform in connection with its sale to a national competitor. Represented Fulcrum Equity in its acquisition of CarePlus Medical.Represented Fulcrum Equity in its acquisition of Liberation Way.